These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19804709)

  • 21. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality criteria for early signals of possible adverse drug reactions.
    Edwards IR; Lindquist M; Wiholm BE; Napke E
    Lancet; 1990 Jul; 336(8708):156-8. PubMed ID: 1973481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
    Schäublin M
    Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports.
    Aronson JK
    Expert Rev Clin Pharmacol; 2015; 8(4):399-409. PubMed ID: 26018632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causality assessment in drug-induced liver injury.
    Hayashi PH
    Semin Liver Dis; 2009 Nov; 29(4):348-56. PubMed ID: 19826968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA; Humphries JE; Crean S; Reynolds MW
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ["Re-evaluation upon suspected event" is an approach for post-marketing clinical study: lessons from adverse drug events related to Bupleuri Radix preparations].
    Wu SX; Sun HF; Yang XH; Long HZ; Ye ZG; Ji SL; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2983-8. PubMed ID: 25423845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase.
    Cliff-Eribo KO; Choonara I; Dodoo A; Darko DM; Sammons H
    Expert Opin Drug Saf; 2015; 14(12):1827-33. PubMed ID: 26436964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Safety of medicinal products and reporting of adverse drug reactions].
    Skibicka I; Maciejczyk A
    Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
    Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular side effects from herbal medicines and nutritional supplements.
    Fraunfelder FW
    Am J Ophthalmol; 2004 Oct; 138(4):639-47. PubMed ID: 15488795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data.
    Solomon C; Gröner A; Ye J; Pendrak I
    Thromb Haemost; 2015 Apr; 113(4):759-71. PubMed ID: 25502954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014.
    Teo DC; Ng PS; Tan SH; Lim AT; Toh DS; Chan SY; Cheong HH
    BMC Complement Altern Med; 2016 Jul; 16():192. PubMed ID: 27389194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Trends in drug-induced liver injury based on reports of adverse reactions to PMDA in Japan].
    Sudo C; Maekawa K; Segawa K; Hanatani T; Sai K; Saito Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2012; (130):66-70. PubMed ID: 23243990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peer review and the process of publishing of adverse drug event reports.
    Karch SB
    J Forensic Leg Med; 2007 Feb; 14(2):79-84. PubMed ID: 17654770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety issues in herbal medicine: implications for the health professions.
    Drew AK; Myers SP
    Med J Aust; 1997 May; 166(10):538-41. PubMed ID: 9196487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The International Society of Pharmacovigilance (ISoP) Special Interest Group on Herbal and Traditional Medicines: Towards Progress in Pharmacovigilance for Herbal and Traditional Medicines and Other "Natural Health" Products.
    Barnes J
    Drug Saf; 2020 Jul; 43(7):619-622. PubMed ID: 32328906
    [No Abstract]   [Full Text] [Related]  

  • 39. A systematic review of the reporting of adverse events associated with medical herb use among children.
    Gardiner P; Adams D; Filippelli AC; Nasser H; Saper R; White L; Vohra S
    Glob Adv Health Med; 2013 Mar; 2(2):46-55. PubMed ID: 24416663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case reports of suspected adverse drug reactions: case reports were dismissed too quickly.
    Vandenbroucke JP
    BMJ; 2006 Feb; 332(7539):488. PubMed ID: 16497772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.